Literature DB >> 8468134

Oxygen affinities of metronidazole-resistant and -sensitive stocks of Giardia intestinalis.

J E Ellis1, J M Wingfield, D Cole, P F Boreham, D Lloyd.   

Abstract

The common protozoon, Giardia intestinalis, parasitizes the upper small intestine of man, and is often refractory to treatment by metronidazole. Defective oxygen-scavenging mechanisms have been implicated as a cause of metronidazole resistance of another flagellate Trichomonas vaginalis, where metronidazole is also the most common drug treatment. Oxygen consumption of six clinical isolates of G. intestinalis and one line selected for resistance to metronidazole was measured over 0-50 microM-O2 using an oxygen electrode open for gas exchange. At > 30 microM-O2, inhibition of respiration was demonstrated in all seven stocks. Apparent oxygen affinities (KmO2) were found to range from 0.5 to 5.2 microM-O2; however, isolates from patients who failed to respond to treatment with metronidazole did not have measurably defective O2-scavenging capabilities compared with metronidazole-sensitive isolates. These strains did, however, show elevated NADPH-oxidase activities compared with metronidazole-sensitive strains. Results indicate that biochemical mechanisms of drug resistance in G. intestinalis may be quite different from those operating in T. vaginalis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8468134     DOI: 10.1016/0020-7519(93)90095-g

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  15 in total

1.  A metronidazole-resistant isolate of Blastocystis spp. is susceptible to nitric oxide and downregulates intestinal epithelial inducible nitric oxide synthase by a novel parasite survival mechanism.

Authors:  Haris Mirza; Zhaona Wu; Fahad Kidwai; Kevin S W Tan
Journal:  Infect Immun       Date:  2011-09-19       Impact factor: 3.441

Review 2.  Drug targets and mechanisms of resistance in the anaerobic protozoa.

Authors:  P Upcroft; J A Upcroft
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

3.  Purification and molecular characterization of the NAD(+)-dependent acetaldehyde/alcohol dehydrogenase from Entamoeba histolytica.

Authors:  I Bruchhaus; E Tannich
Journal:  Biochem J       Date:  1994-11-01       Impact factor: 3.857

4.  Giardial triosephosphate isomerase as possible target of the cytotoxic effect of omeprazole in Giardia lamblia.

Authors:  Horacio Reyes-Vivas; Ignacio de la Mora-de la Mora; Adriana Castillo-Villanueva; Lilian Yépez-Mulia; Gloria Hernández-Alcántara; Rosalia Figueroa-Salazar; Itzhel García-Torres; Saúl Gómez-Manzo; Sara T Méndez; América Vanoye-Carlo; Jaime Marcial-Quino; Angélica Torres-Arroyo; Jesús Oria-Hernández; Pedro Gutiérrez-Castrellón; Sergio Enríquez-Flores; Gabriel López-Velázquez
Journal:  Antimicrob Agents Chemother       Date:  2014-09-15       Impact factor: 5.191

5.  Pyruvate:ferredoxin oxidoreductase and thioredoxin reductase are involved in 5-nitroimidazole activation while flavin metabolism is linked to 5-nitroimidazole resistance in Giardia lamblia.

Authors:  David Leitsch; Anita G Burgess; Linda A Dunn; Kenia G Krauer; Kevin Tan; Michael Duchêne; Peter Upcroft; Lars Eckmann; Jacqueline A Upcroft
Journal:  J Antimicrob Chemother       Date:  2011-05-22       Impact factor: 5.790

6.  Trichomonas vaginalis flavin reductase 1 and its role in metronidazole resistance.

Authors:  David Leitsch; Brian D Janssen; Daniel Kolarich; Patricia J Johnson; Michael Duchêne
Journal:  Mol Microbiol       Date:  2013-11-20       Impact factor: 3.501

7.  Down-regulation of flavin reductase and alcohol dehydrogenase-1 (ADH1) in metronidazole-resistant isolates of Trichomonas vaginalis.

Authors:  David Leitsch; Mirjana Drinić; Daniel Kolarich; Michael Duchêne
Journal:  Mol Biochem Parasitol       Date:  2012-03-17       Impact factor: 1.759

8.  Nitroimidazole action in Entamoeba histolytica: a central role for thioredoxin reductase.

Authors:  David Leitsch; Daniel Kolarich; Iain B H Wilson; Friedrich Altmann; Michael Duchêne
Journal:  PLoS Biol       Date:  2007-08       Impact factor: 8.029

9.  The old and new therapeutic approaches to the treatment of giardiasis: where are we?

Authors:  Haendel G N O Busatti; Joseph F G Santos; Maria A Gomes
Journal:  Biologics       Date:  2009-07-13

Review 10.  Drug Resistance in the Microaerophilic Parasite Giardia lamblia.

Authors:  David Leitsch
Journal:  Curr Trop Med Rep       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.